MedPath

Opioid Analgesic Reduction Study (OARS) - Pilot

Phase 3
Completed
Conditions
Post Operative Pain
Interventions
Drug: OPIOID
Drug: NON-OPIOID
Registration Number
NCT05283499
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.

Detailed Description

A double-blind stratified randomized clinical trial is being conduct on the management of post-surgical pain after extraction of impacted third mandibular molars Subjects will be randomly assigned to either the OPIOID or NON-OPIOID group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria
  • Adult men and non-pregnant women who are at least 18 years of age, who are able to refrain from driving or operating heavy machinery while taking the study medication will be able to participate.
  • Subjects who are English speaking and are able to provide consent will be considered.
  • Subjects must be in generally good health and able to take ibuprofen, paracetamol (acetaminophen), and hydrocodone.
Exclusion Criteria

Subjects who self-report the following history will be excluded from participating:

  • Individual under the age of 18

  • History of gastrointestinal bleeding and/or peptic ulcer

  • History of renal disease (excluding kidney stones)

  • History of hepatic disease

  • History of bleeding disorder

  • History of respiratory depression

  • Any prior respiratory effect of an opioid or other anesthetic drug that required respiratory support postoperatively

  • Active or untreated asthma

  • History of known allergic reaction to ibuprofen, acetaminophen, hydrocodone, and/or anesthesia

  • Currently taking any of the following medications:

    • CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), which may increase plasma concentrations of hydrocodone bitartrate and acetaminophen and prolong opioid adverse reactions, and which may cause potentially fatal respiratory depression
    • CNS depressants.
  • Consumes 3 or more alcoholic drinks every day and/or has a history of alcoholism

  • History of drug or alcohol abuse (excludes marijuana use)

  • Family history of drug or alcohol abuse in a first degree relative

  • Has had one or more opioid prescription filled within the past 6 months

  • Currently pregnant or lactating

Patients would also be excluded due to any additional criteria that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study which includes:

  • Prior participation in this study
  • Inability or refusal to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OpioidOPIOIDCombination analgesic of hydrocodone 5mg/acetaminophen350 mg
Non-OpioidNON-OPIOIDCombination analgesic of ibuprofen 400mgacademinophen 350mg
Primary Outcome Measures
NameTimeMethod
Pain LevelAverage for the first seven days post surgery

Pain (self reported by subject) rated on numeric rating scale (0=no pain, 10=worst pain

Secondary Outcome Measures
NameTimeMethod
Sleep QualityAverage for the first seven nights post surgery

Quality of overall sleep (self reported by subject) rated on numeric rating scale (0=best possible sleep possible, 10=worst possible sleep possible)

Pain Interference Scale (Patient Report Outcomes Measurement Information System - PROMIS 6b )Average for the first seven days post surgery

Impact of pain on subject's ability to perform normal daily functions. The sum of six questions rated on a 5 point Likert Scale (1=not at all or never, 2=a little bit or rarely, 3=somewhat or sometimes, 4=quite a bit or often and 5=very much or always)

The six questions are: 1) how much did pain interfere with your enjoyment of life, 2) how much did pain interfere with your ability to concentrate, 3) how much did pain interfere with your day to day activities, 4) how much did pain interfere with your enjoyment of recreational activities 5) how much did pain interfere with your tasks away form and home and 6) how often did pain keep you from socializing with others?

Minimum = 6, Maximum = 30; lower is better and higher is worse outcome

Overall SatisfactionAverage for the first seven days post surgery

Subject's rating of overall satisfaction with the analgesic provided after surgery on a 5 point Likert Scale (1=very satisfied, 2=satisfied, 3=neither satisfied or dissatisfied, 4=dissatisfied, 5=very dissatisfied)

Trial Locations

Locations (5)

University of Rochester

🇺🇸

Rochester, New York, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

University of Illinois Chicago

🇺🇸

Chicago, Illinois, United States

University of Maryland

🇺🇸

Baltimore, Maryland, United States

Rutgers University

🇺🇸

Newark, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath